Keyphrases
Botulinum Neurotoxin (BoNT)
100%
Neuromuscular Junction
100%
Density Change
100%
Orbicularis Oculi muscle
100%
Insulin-like Growth Factor 1 Receptor (IGF1R)
57%
Corticotropin-releasing Factor
57%
Eyelid
42%
Botulinum Toxin Injection
28%
Clinical Efficacy
14%
Muscle Function
14%
Blepharospasm
14%
Focal Dystonia
14%
Number of Injections
14%
Muscle Spasm
14%
Tion
14%
Drug Effectiveness
14%
Hemifacial Spasm
14%
Toxin Exposure
14%
Duration of Effect
14%
Muscle Paralysis
14%
Negative Side Effects
14%
Medicine and Dentistry
Neuromuscular Junction
100%
Orbicularis Oculi Muscle
100%
Clostridium Botulinum Type A
100%
Receptor
50%
Corticotropin Releasing Factor
50%
Fibrinogen
50%
Somatomedin
50%
Eyelid
37%
Lifespan
12%
Muscle Function
12%
Side Effect
12%
Botulinum Toxin A
12%
Sprouting
12%
Paralysis
12%
Drug Efficacy
12%
Hemifacial Spasm
12%
Blepharospasm
12%
Muscle Spasm
12%
Focal Dystonia
12%
Neuroscience
Neuromuscular Junction
100%
Orbicularis Oculi Muscle
100%
Clostridium Botulinum Type A
100%
Somatomedin
50%
Corticotropin-Releasing Hormone
50%
Fibrinogen
50%
Receptor
50%
Eyelid
37%
Dystonia
12%
Blepharospasm
12%
Botulinum Toxin A
12%
Pharmacology, Toxicology and Pharmaceutical Science
Clostridium Botulinum Type A
100%
Receptor
50%
Corticotropin Releasing Factor
50%
Somatomedin
50%
Fibrinogen
50%
Leporidae
25%
Botulinum Toxin A
12%
Side Effect
12%
Paralysis
12%
Muscle Spasm
12%
Hemifacial Spasm
12%
Blepharospasm
12%
Focal Dystonia
12%